Equifax (EFX)
NYSEIndustrialsConsulting ServicesSnapshot 2026-11-04
$192.21+2.39%
Close 2026-11-04 · 1-day change
NYSEIndustrialsConsulting ServicesSnapshot 2026-11-04
Research Workspace
Put EFX beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Industrials is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Achieve EPS near $8.54 in 2026: Diluted EPS: $1.79 per share.
View ThesisRevenue growth is accelerating — up about 11% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on earnings delivery, margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 39% in its worst 12-month stretch.
View RiskEquifax's diversified markets growth must keep compounding to justify the price. Revenue grew 10% in the third quarter. The company beat its earnings estimate by 2.7%. It trades at 23 times earnings. Peers trade at 22 times earnings. The price reflects less growth than we forecast. The primary pillar is under pressure. Diluted EPS is $1.79 per share. Peer multiples imply a price about 15% below where it trades. The thesis is on watch.
Trailing returns as of 2026-11-04. EFX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 24 analysts currently covering EFX (as of Nov 2026).
Based on 16 Wall Street analysts offering 12-month price targets for EFX in the last 4 months.
Continue this research
Compare EFX with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| EFX Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 14 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Research & Consulting Services — fair value, gap to price, and forward P/E.
Compare the value case
Put EFX next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Drive revenue growth across diversified markets and products
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $192.21
The last 12 months of price, then the range of analyst 12-month targets from today’s $192.21.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
2026 EPS and over $1 billion free cash flow outlook support growth and cash generation despite mortgage headwinds.
Advances: Drive revenue growth across diversified markets and products
Earnings-call disclosures on execution and outlook may confirm diversified growth objectives.
Q3 results and updated guidance drove a sharp share-price rise, indicating a meaningful positive catalyst.
Advances: Drive revenue growth across diversified markets and products
Official 10% revenue growth, diversified-market growth, and shareholder returns confirm operating execution.
Advances: Accelerate new product innovation using EFX Cloud, EFX.AI and data
New mortgage-score offering demonstrates product innovation using Equifax data.
Advances: Drive double-digit revenue growth with new product innovation
Increased interest in compliance software supports product innovation growth.
Threatens: Drive revenue growth across diversified markets and products
Mortgage credit-report rule changes could weaken a key revenue channel.
Threatens: Drive revenue growth across diversified markets and products
Renewed criticism and falling bureau shares reflect material risk from credit-scoring alternatives.
